Zuckerman AD - Search Results

1

Persistent use of dupilumab in adults with asthma or chronic rhinosinusitis with nasal polyps.

Corey KB, Moore R, Zuckerman AD, Littlejohn M, Cahill KN. Corey KB, et al. Among authors: zuckerman ad. Ann Allergy Asthma Immunol. 2024 Mar;132(3):390-391. doi: 10.1016/j.anai.2023.11.008. Epub 2023 Nov 20. Ann Allergy Asthma Immunol. 2024. PMID: 37981023 No abstract available.

2

Individual and Community-Level Characteristics and Adherence to Specialty Medications.

Kibbons AM, Moore R, Choi L, Peter M, Zuckerman AD. Kibbons AM, et al. Among authors: zuckerman ad. J Pharm Pract. 2024 Apr;37(2):279-286. doi: 10.1177/08971900221131933. Epub 2022 Oct 7. J Pharm Pract. 2024. PMID: 36206399 Clinical Trial.

3

Patient-Tailored Interventions to Improve Specialty Medication Adherence: Results from a Prospective Randomized Controlled Trial.

Kibbons AM, Moore R, Choi L, Zuckerman AD. Kibbons AM, et al. Among authors: zuckerman ad. Am J Med. 2023 Jul;136(7):694-701.e1. doi: 10.1016/j.amjmed.2023.03.007. Epub 2023 Apr 5. Am J Med. 2023. PMID: 37028694 Free PMC article. Clinical Trial.

4

Financial impact of integrated specialty pharmacy efforts to avoid oral anticancer medication waste.

Looney B, Crumb J, White S, Jones G, Moore RP, Choi L, Zuckerman AD, Whelchel K. Looney B, et al. Among authors: zuckerman ad. J Manag Care Spec Pharm. 2024 May;30(5):465-474. doi: 10.18553/jmcp.2024.30.5.465. J Manag Care Spec Pharm. 2024. PMID: 38701029 Free PMC article.

5

Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model.

Renfro CP, Donald DR, Kibbons AM, Littlejohn MD, Bryan ED, Nix R, Cherry E, Zuckerman AD. Renfro CP, et al. Among authors: zuckerman ad. Am J Health Syst Pharm. 2024 Sep 25:zxae256. doi: 10.1093/ajhp/zxae256. Online ahead of print. Am J Health Syst Pharm. 2024. PMID: 39320071

6

Primary medication nonadherence to oral oncology specialty medications.

Zuckerman AD, Shah NB, Perciavalle K, Looney B, Peter ME, DeClercq J, Moore R, Choi L, Reynolds VW. Zuckerman AD, et al. J Am Pharm Assoc (2003). 2022 May-Jun;62(3):809-816.e1. doi: 10.1016/j.japh.2022.01.005. Epub 2022 Jan 6. J Am Pharm Assoc (2003). 2022. PMID: 35065885

7

[No title available]

[No authors listed] [No authors listed] PMID: 38352722

8

Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy.

Carver AB, Zuckerman AD, DeClercq J, Choi L, Chastain CA. Carver AB, et al. Among authors: zuckerman ad. Open Forum Infect Dis. 2020 Nov 26;7(12):ofaa569. doi: 10.1093/ofid/ofaa569. eCollection 2020 Dec. Open Forum Infect Dis. 2020. PMID: 33409333 Free PMC article.

9

Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions.

Wyatt H, Zuckerman AD, Hughes ME, Arnall J, Miller R. Wyatt H, et al. Among authors: zuckerman ad. J Oncol Pharm Pract. 2022 Apr;28(3):627-634. doi: 10.1177/10781552211072467. Epub 2022 Jan 17. J Oncol Pharm Pract. 2022. PMID: 35037778

10

Development, implementation, and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacy.

Zuckerman AD, Shah NB, Peter ME, Jolly JA, Kelley TN. Zuckerman AD, et al. Am J Health Syst Pharm. 2021 May 24;78(11):972-981. doi: 10.1093/ajhp/zxab082. Am J Health Syst Pharm. 2021. PMID: 33693451 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters